1 |
Li H, Xiao N, Wang Y, Wang R, Chen Y, Pan W, Liu D, Li S, Sun J, Zhang K, Sun Y, Ge X. Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKIgamma. Oncogene. 2017;36:5668-5680. doi:10.1038/onc.2017.166.
DOI
|
2 |
Wang X, Jin C, Tang Y, Tang LY, Zhang YE. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. J Biol Chem. 2013;288:21784-21792. doi:10.1074/jbc.M113.472704.
DOI
|
3 |
Shen W, Pang H, Liu J, Zhou J, Zhang F, Liu L, Ma N, Zhang N, Zhang H, Liu L. Epithelial-mesenchymal transition contributes to docetaxel resistance in human non-small cell lung cancer. Oncol Res. 2014;22:47-55. doi:10.3727/096504014X14098532393473.
DOI
|
4 |
Spano D, Heck C, De Antonellis P, Christofori G, Zollo M. Molecular networks that regulate cancer metastasis. Semin Cancer Biol. 2012;22:234-249. doi:10.1016/j.semcancer. 2012.03.006.
DOI
|
5 |
Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559-1564. doi:10.1126/science.1203543.
DOI
|
6 |
Masoud V, Pages G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol. 2017;8:120-134. doi:10.5306/wjco.v8.i2.120.
DOI
|
7 |
Kwon A, Lee HL, Woo KM, Ryoo HM, Baek JH. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion. Mol Cells. 2013;36:548-555. doi:10.1007/s10059-013-0233-4.
DOI
|
8 |
Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M et al. Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget. 2014;5:4603-4650. doi:10.18632/oncotarget.2209.
|
9 |
Radisky DC. Epithelial-mesenchymal transition. J Cell Sci. 2005;118:4325-4326. doi:10.1242/jcs.02552.
DOI
|
10 |
Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112: 1776-1784. doi:10.1172/JCI20530.
DOI
|
11 |
Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K, Ginsberg MH. Talin phosphorylation by Cdk5 regulates Smurf1- mediated talin head ubiquitylation and cell migration. Nat Cell Biol. 2009;11:624-630. doi:10.1038/ncb1868.
DOI
|
12 |
Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD, Pollack JR. SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One. 2011;6:e23924. doi:10.1371/journal.pone.0023924.
DOI
|
13 |
Schwamborn JC, Muller M, Becker AH, Puschel AW. Ubiquitination of the GTPase Rap1B by the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity. EMBO J. 2007;26:1410-1422. doi:10.1038/sj.emboj.7601580.
DOI
|
14 |
Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science. 2003;302:1775-1779. doi:10.1126/science.1090772.
DOI
|
15 |
Jin C, Yang YA, Anver MR, Morris N, Wang X, Zhang YE. Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. Cancer Res. 2009;69:735-740. doi:10.1158/0008-5472.CAN-08-1463.
DOI
|
16 |
Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398: 422-426. doi:10.1038/18884.
DOI
|
17 |
Sahai E, Garcia-Medina R, Pouyssegur J, Vial E. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol. 2007;176:35-42. doi:10.1083/jcb.200605135.
DOI
|
18 |
Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P, Sakuma R, Luga V, Roncari L, Attisano L, Wrana JL. Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell. 2009;137:295-307. doi:10.1016/j.cell.2009.02.025.
DOI
|
19 |
Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol. 1999;155:703-710.
DOI
|
20 |
Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 1999;18:2883-2891. doi:10.1038/sj.onc.1202627.
DOI
|
21 |
Yun KJ, Han WC, Choi SC, Kim TH. Immunohistochemical Study of beta-catenin Expression between Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Res Treat. 2002;34:117-121. doi:10.4143/crt.2002.34.2.117.
DOI
|
22 |
Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer. 1999;35:60-65.
DOI
|
23 |
Boonanantanasarn K, Lee HL, Baek K, Woo KM, Ryoo HM, Baek JH, Kim GS. EGF Inhibits Wnt/beta-Catenin-Induced Osteoblast Differentiation by Promoting beta-Catenin Degradation. J Cell Biochem. 2015;116:2849-2857. doi:10.1002/jcb.25231.
DOI
|
24 |
Hoschuetzky H, Aberle H, Kemler R. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol. 1994;127: 1375-1380.
DOI
|
25 |
Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987;1:1398-1402.
|
26 |
Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183-232.
DOI
|
27 |
Menard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, Cascinelli N. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res. 2002;8:520-525.
|
28 |
Jarrard DF, Blitz BF, Smith RC, Patai BL, Rukstalis DB. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate. 1994;24:46-53.
DOI
|
29 |
Ribeiro FA, Noguti J, Oshima CT, Ribeiro DA. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach. Anticancer Res. 2014;34:1547-1552.
|
30 |
Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M. Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem. 1999;274:36734-36740.
DOI
|
31 |
Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem. 2007;282:11221-11229. doi:10.1074/jbc.M611871200.
DOI
|
32 |
Hazan RB, Norton L. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem. 1998;273:9078-9084.
DOI
|